722 related articles for article (PubMed ID: 23202417)
1. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
Nurchi VM; Crisponi G; Crespo-Alonso M; Lachowicz JI; Szewczuk Z; Cooper GJ
Dalton Trans; 2013 May; 42(17):6161-70. PubMed ID: 23202417
[TBL] [Abstract][Full Text] [Related]
2. Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients.
Lu J; Chan YK; Gamble GD; Poppitt SD; Othman AA; Cooper GJ
Drug Metab Dispos; 2007 Feb; 35(2):221-7. PubMed ID: 17108057
[TBL] [Abstract][Full Text] [Related]
3. Complex formation equilibria of polyamine ligands with copper(II) and zinc(II).
Nurchi VM; Crisponi G; Sanna G; Pérez-Toro I; Niclos-Gutierrez J; Gonzalez-Perez MJ; Domínguez Martín A
J Inorg Biochem; 2019 May; 194():26-33. PubMed ID: 30807891
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
5. Coordination of Cu2+ ions to C2 symmetric pseudopeptides derived from valine.
Blasco S; Burguete MI; Clares MP; García-España E; Escorihuela J; Luis SV
Inorg Chem; 2010 Sep; 49(17):7841-52. PubMed ID: 20681616
[TBL] [Abstract][Full Text] [Related]
6. Mononuclear [(BP)(2)MX](n+) (M = Cu(2+), Co(2+), Zn(2+); X = OH(2), Cl(-)) complexes with a new biphenyl appended N-bidentate ligand: structural, spectroscopic, solution equilibrium and ligand dynamic studies.
Sabiah S; Varghese B; Murthy NN
Dalton Trans; 2009 Nov; (44):9770-80. PubMed ID: 19885522
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, potentiometric, kinetic, and NMR Studies of 1,4,7,10-tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions.
Kálmán FK; Baranyai Z; Tóth I; Bányai I; Király R; Brücher E; Aime S; Sun X; Sherry AD; Kovács Z
Inorg Chem; 2008 May; 47(9):3851-62. PubMed ID: 18380456
[TBL] [Abstract][Full Text] [Related]
8. Potentiometric and spectrophotometric study of a new dipodal ligand N,N'-bis{2-[(2-hydroxybenzylidine)amino]ethyl}malonamide with Co(II), Ni(II), Cu(II) and Zn(II).
Sahoo SK; Muthu SE; Baral M; Kanungo BK
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Mar; 63(3):574-86. PubMed ID: 16024268
[TBL] [Abstract][Full Text] [Related]
9. On the possible roles of N-terminal His-rich domains of Cu,Zn SODs of some Gram-negative bacteria.
Arus D; Jancsó A; Szunyogh D; Matyuska F; Nagy NV; Hoffmann E; Körtvélyesi T; Gajda T
J Inorg Biochem; 2012 Jan; 106(1):10-8. PubMed ID: 22105012
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.
Peana M; Medici S; Nurchi VM; Lachowicz JI; Crisponi G; Garribba E; Sanna D; Zoroddu MA
J Inorg Biochem; 2017 Jun; 171():18-28. PubMed ID: 28343065
[TBL] [Abstract][Full Text] [Related]
11. NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies.
Kubíček V; Böhmová Z; Ševčíková R; Vaněk J; Lubal P; Poláková Z; Michalicová R; Kotek J; Hermann P
Inorg Chem; 2018 Mar; 57(6):3061-3072. PubMed ID: 29488748
[TBL] [Abstract][Full Text] [Related]
12. Copper(II) and zinc(II) ion binding properties of a MAP type branched ligand with histidines as surface functionalities.
Kolozsi A; Vosekalna I; Martinek T; Larsen E; Gyurcsik B
Dalton Trans; 2009 Aug; (29):5647-54. PubMed ID: 20449077
[TBL] [Abstract][Full Text] [Related]
13. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity.
Nurchi VM; Crisponi G; Arca M; Crespo-Alonso M; Lachowicz JI; Mansoori D; Toso L; Pichiri G; Amelia Santos M; Marques SM; Niclós-Gutiérrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z; Antonietta Zoroddu M; Peana M
J Inorg Biochem; 2014 Dec; 141():132-143. PubMed ID: 25260149
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, spectroscopy, and binding constants of ketocatechol-containing iminodiacetic acid and its Fe(III), Cu(II), and Zn(II) complexes and reaction of Cu(II) complex with H₂O₂ in aqueous solution.
Gao J; Xing F; Bai Y; Zhu S
Dalton Trans; 2014 Jun; 43(21):7964-78. PubMed ID: 24715002
[TBL] [Abstract][Full Text] [Related]
15. Molecular factors affecting the complex formation between deferiprone (L1) and Cu(II). Possible implications on efficacy and toxicity.
Pashalidis I; Kontoghiorghes GJ
Arzneimittelforschung; 2001; 51(12):998-1003. PubMed ID: 11799848
[TBL] [Abstract][Full Text] [Related]
16. Complex formation equilibria of Cu
Lachowicz JI; Nurchi VM; Crisponi G; Jaraquemada-Pelaez MG; Caltagirone C; Peana M; Zoroddu MA; Szewczuk Z; Cooper GJ
Eur J Pharm Sci; 2017 Jan; 97():158-169. PubMed ID: 27838251
[TBL] [Abstract][Full Text] [Related]
17. Metal binding affinities of Arabidopsis zinc and copper transporters: selectivities match the relative, but not the absolute, affinities of their amino-terminal domains.
Zimmermann M; Clarke O; Gulbis JM; Keizer DW; Jarvis RS; Cobbett CS; Hinds MG; Xiao Z; Wedd AG
Biochemistry; 2009 Dec; 48(49):11640-54. PubMed ID: 19883117
[TBL] [Abstract][Full Text] [Related]
18. Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments.
Lu J; Gong D; Choong SY; Xu H; Chan YK; Chen X; Fitzpatrick S; Glyn-Jones S; Zhang S; Nakamura T; Ruggiero K; Obolonkin V; Poppitt SD; Phillips AR; Cooper GJ
Diabetologia; 2010 Jun; 53(6):1217-26. PubMed ID: 20221822
[TBL] [Abstract][Full Text] [Related]
19. Determination of stability constants of Cu(I), Cd(II) & Zn(II) complexes with thiols using fluorescent probes.
Walsh MJ; Ahner BA
J Inorg Biochem; 2013 Nov; 128():112-23. PubMed ID: 23954481
[TBL] [Abstract][Full Text] [Related]
20. Complex formation processes of terminally protected peptides containing two or three histidyl residues. Characterization of the mixed metal complexes of peptides.
Rajković S; Kállay C; Serényi R; Malandrinos G; Hadjiliadis N; Sanna D; Sóvágó I
Dalton Trans; 2008 Oct; (37):5059-71. PubMed ID: 18802621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
